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Summary: Macrophages have long been center stage in the host
response to microbial infection, but only in the past 10–15 years has
there been a growing appreciation for their role in helminth infection
and the associated type 2 response. Through the actions of the IL-4
receptor a (IL-4Ra), type 2 cytokines result in the accumulation of
macrophages with a distinctive activation phenotype. Although our
knowledge of IL-4Ra-induced genes is growing rapidly, the specific
functions of these macrophages have yet to be established in most dis-
ease settings. Understanding the interplay between IL-4Ra-activated
macrophages and the other cellular players is confounded by the enor-
mous transcriptional heterogeneity within the macrophage population
and by their highly plastic nature. Another level of complexity is added
by the new knowledge that tissue macrophages can be derived either
from a resident prenatal population or from blood monocyte recruit-
ment and that IL-4 can increase macrophage numbers through prolifer-
ative expansion. Here, we review current knowledge on the
contribution of macrophages to helminth killing and wound repair,
with specific attention paid to distinct cellular origins and plasticity
potential.
Keywords: IL-4 receptor, monocyte, macrophage, wound repair, inflammation,
helminth infection
Introduction
Infection with multicellular parasites represents one of the
most significant challenges to both veterinary and public
health. Medically relevant multicellular parasites are called
‘helminths’, a term that does not accurately reflect the vast
phylogenetic diversity of this group, which includes the
platyhelminths (flukes and tapeworms) and nematodes
(roundworms). These animal phyla diverged over 1 billion
years ago, predating the split between vertebrates and inver-
tebrates (1). Despite the phylogenetic distance between
them, helminths as well as many insects induce a character-
istic immune response that at its core, features the produc-
tion of interleukin-4 (IL-4) and IL-13 by T-helper 2 (Th2)
cells and a range of innate cells. Thus, we are apparently
hardwired to mount a type 2 response on exposure to mul-
ticellular parasites (2).
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In humans, helminths predominantly cause disease in
developing countries but are a major veterinary problem
throughout the world and often establish long-lasting infec-
tions that can last years and even decades. As a consequence,
these infections are rarely lethal but can have devastating
effects on life quality (3, 4). Often, however, infections are
asymptomatic or associated with less obvious repercussions
(e.g. growth retardation, blunted mental development, etc.)
caused by nutritional restrictions imposed on the host (5).
To maintain fitness, the infected individual must cope with
large motile foreign organisms that cannot easily be digested
or removed, and for which an aggressive host response
would be self-damaging. Further, these parasites often
directly damage host tissue during migration or feeding.
The host must thus strike a balance between immune sup-
pression to minimize self-harm, the repair of damaged tis-
sue and a sufficiently robust anti-worm response to keep
parasite numbers below a level that compromises fitness.
Type 2 immunity appears to be the response mammals have
evolved to cope with this challenge. Th2 cells that produce
IL-4, IL-5, IL-9, IL-10, and IL-13 and B cells producing
immunoglobulin E (IgE) are the central players in the adap-
tive type 2 response and the innate cells associated with type
2 cytokines include eosinophils, mast cells, basophils, mac-
rophages, and type 2 innate lymphoid cells (ILC2).
Together, these pathways promote parasite killing and
expulsion but are also key components of tissue repair path-
ways that are fundamentally non-inflammatory (2, 6, 7).
In this review, we focus on the role of macrophages in
keeping the host fit in the context of a type 2 response
induced by helminth infection. Macrophages have long been
center stage as the target of Th1-type responses with a clear
role in containment of microbial pathogens, particularly
intracellular bacteria and protozoa. The function of macro-
phages activated by Th2 cytokines has been far more diffi-
cult to establish, despite their abundance in almost every
helminth infection as well as other type 2 conditions such
as allergy and asthma. While IL-4Ra ligation by either IL-4
or IL-13 has a dramatic effect on the macrophage transcrip-
tional landscape (8, 9), the specific functions of macrophag-
es activated via the IL-4Ra have yet to be fully defined.
Here, we use the term alternatively activated macrophage
(ΑΑΜΦ) to define macrophage phenotypes that rely on the
IL-4Ra (10). However, even when considering activation
via a single receptor there is a broad heterogeneity of con-
text-dependent macrophage phenotypes observable. This
makes it difficult to identify unifying functional properties
of ΑΑΜΦ. With an emphasis on our own research, we
highlight here the knowledge that has been gained from
studying macrophage activation in helminth models, which
has provided broad insight into macrophage biology.
Macrophage proliferation
We have been using a murine model of filariasis, Litomosoides
sigmodontis, to understand the mechanisms of resistance and
susceptibility to filarial nematode infection. Infective larvae
(L3) invade via the skin, migrate through the lymphatics,
and enter the pleural cavity, where they mature to adult-
hood. In susceptible BALB/c mice, the adult worms pro-
duce blood-circulating offspring (microfilariae) by day 50
postinfection. In resistant C57BL/6 mice the parasites are
killed in the pleural cavity prior to reaching sexual matu-
rity. This has proved a powerful model for the study of fil-
ariasis (11) and highlighted a critical role for T-regulatory
cells in the susceptible phenotype of BALB/c mice (12). To
investigate the contribution of macrophages to parasite kill-
ing in the resistant C57BL/6 strain, we depleted blood
monocytes to prevent their recruitment to the infection site.
To our surprise, we saw no reduction in the high macro-
phage numbers accumulating in the pleural cavity of
infected mice. Time course assessment over the first
10 days of infection demonstrated that although macro-
phages were steadily increasing in number, their flow
cytometry profile remained essentially the same as in naive
mice, with no evidence of monocyte or neutrophil infiltra-
tion (13). This suggested that the resident macrophage
population was expanding by other means than recruitment
from the blood. Indeed, using both Ki67 staining and a 3 h
BrdU pulse, extensive proliferation of the resident F4/80hi
population was observed (13).
Macrophage expansion and survival had previously been
associated with CSF1R signaling and differentiation of
monocyte derived macrophages (14–17). However, because
helminth-driven macrophage proliferation was independent
from blood monocyte recruitment and the numbers of cells
accumulating at the site of infection were significantly
reduced in IL-4/ mice (13), we tested the possibility that
IL-4 was directly responsible. An injection of IL-4 complex
(IL-4C) [a mixture of IL-4 with anti-IL-4 for increased bio-
activity (18)] into the peritoneal cavity led to dramatic mac-
rophage proliferation (13). Remarkably, proliferative
expansion was not restricted to the serous cavities but was
observed in the liver (13), spleen, and lungs (authors’
unpublished observation). This was consistent with previ-
ously published data showing that IL-4 delivery, either in
complex form or by mini-osmotic pump, led to
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macrophage hyperplasia in the liver, spleen and bone mar-
row (18). In both the Milner et al. study and ours (13, 18–
20), macrophage expansion following IL-4C delivery was
independent of the adaptive immune system, occurring in
RAG/ mice but not in Stat-6/ or IL-4Ra/ animals.
IL-4C injection allowed us to take a reductionist approach
to address the factors that contribute to helminth-driven
macrophage proliferation. Using macrophage-intrinsic com-
petitive bone marrow (BM) chimeras in which Ly5.1+ WT
mice are reconstituted with a 1:1 mix of Ly5.1+ WT and IL-
4Ra/ Ly5.2+ BM, we established that IL-4 acts directly
on the macrophages and IL-4Ra expression is essential to
initiate a program of proliferation (19). However, important
differences between the IL-4C model and L. sigmodontis infec-
tion were observed using these 50:50 WT:IL-4Ra/ chi-
meras. No BrdU incorporation into IL-4Raneg cells was
observed following IL-4C injection, but during the early
stages of L. sigmodontis infection, IL-4Raneg cells did incorpo-
rate BrdU, albeit at significantly lower level than the WT
cells. As discussed below, we subsequently identified CSF1-
dependent mechanisms to be responsible for the residual
proliferative expansion of these cells during infection. Criti-
cally, IL-4Ra positive macrophages have a competitive
advantage, proliferating to a greater extent and eventually
outnumbering their IL-4Ra negative counterparts (19). Fur-
ther, both macrophage proliferation and numbers are
reduced in IL-4/ and IL-4Ra/ mice in all infection
models tested, emphasizing the central role of IL-4 in driv-
ing macrophage accumulation during infection. Because IL-
13 can also signal through the IL-4Ra we addressed whether
IL-13 was also capable of inducing macrophage prolifera-
tion. We generated an IL-13 complex and demonstrated that
it was equivalently able to drive macrophage proliferation
when delivered intraperitoneally (19). However, a role for
IL-13-mediated proliferation in a physiological setting has
yet to be established.
The source of IL-4 (or IL-13) that drives macrophage
proliferation during helminth infection is likely to vary with
tissue and stage of infection (6) and may include mast cells,
eosinophils, or innate lymphoid cells among others. How-
ever, our data suggest that during infection, CD4+ lympho-
cytes are required to generate significant macrophage
numbers. In the absence of either RAG genes or class II,
there is no expansion or alternative activation of macrophag-
es in a peritoneal implant model of filarial infection (21). In
the L. sigmodontis infection model, proliferation does not
occur until the onset of the adaptive immune response and
does not occur in infected RAG-deficient mice (13, 19).
Along with the need for high concentrations of IL-4 (19),
these data strongly suggest a requirement for cognate T-
helper interactions to initiate macrophage proliferation in
the infection context. Although macrophage accumulation in
both IL-4C and infection models is the direct result of IL-4
driven proliferation, anti-apoptotic properties of IL-4 may
also make a significant contribution to the final numbers.
Macrophage provenance
Our discovery that IL-4 could drive expansion of resident
macrophages occurred as a new paradigm in macrophage
biology was unfolding. The established dogma had been
that tissue-resident macrophages were derived from circu-
lating bone marrow-derived monocytes. With new fate
mapping technologies it became apparent that in most
tissues including the serous cavities (22, 23) the resident
macrophages are established prenatally and are retained
throughout the life of the animal through proliferative
self-renewal (reviewed in 24, 25). The notable exceptions
to this rule are macrophages in the skin and GI tract
(26, 27).
To verify the source of proliferating macrophages in our
L. sigmodontis infection model, we used tissue-protected BM
chimeras (13) in which resident macrophages in the body
cavities are protected from radiation damage and thus not
replaced by BM-derived cells. Using the recipient/donor
ratio found in the blood versus the body cavity of naive ani-
mals, it is possible to determine whether the macrophages
in infected tissues are of BM origin or not. Using this
method, we were able to show that the expanding macro-
phage population following both IL-4C injection and L. sigm-
odontis infection were derived from tissue-resident cells (13).
The tissue-protected BM chimeras thus allowed us to for-
mally demonstrate that the expanding cells were not derived
from circulating blood monocytes (13). However, AAMΦ in
the GI tract of nematode infected mice are largely mono-
cyte-derived (28), and we have observed proliferation of
macrophages in the lamina propria of mice infected with the
GI nematode, Heligmosomoides polygyrus (Fig. 1). We thus inves-
tigated whether IL-4-driven proliferative expansion was
restricted to tissue-resident macrophages or if IL-4 could act
similarly on monocyte-derived cells. Using the tissue-pro-
tected chimeras, we demonstrated that injection of thiogly-
collate together with IL-4C stimulates the proliferation of
recruited bone marrow-derived monocytes, while IL-4C
alone stimulates resident cell expansion. Thus the ability of
IL-4 to stimulate proliferation is not restricted to resident
cells (13, 20).
© 2014 The Authors. Immunological Reviews published by John Wiley & Sons Ltd.
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Macrophage self-renewal in most tissues relies on the
CSF-1 receptor (CSF1R) (24), and CSF-1 has been shown to
be required for both the steady state maintenance of resi-
dent peritoneal macrophages as well as recovery of the resi-
dent population by proliferative expansion following an
inflammatory response (29). In our experiments with 50:50
WT:IL-4Ra/ bone marrow chimeras, steady-state prolifer-
ation in PBS-treated animals was not influenced by IL-4Ra
signaling (19), confirming that IL-4 is not needed for local
self-renewal of peritoneal macrophages (30). We hypothe-
sized that instead, IL-4 functioned by enhancing steady state
proliferation, perhaps by CSF1R upregulation or increased
ligand production. To test this, the CSF1R was blocked dur-
ing IL-4C delivery. IL-4-induced proliferation was undimin-
ished in the presence of the CSF1R antibody demonstrating
complete independence from the CSF1R (19). However,
CSF1R blockade during L. sigmodontis infection suggested that
CSF1 does contribute to macrophage proliferation early in
infection but is superseded by IL4 presumably upon entry
of Th2 cells. Supporting this, CSF1R blockade at day 8 post-
infection inhibited macrophage proliferation only in the ani-
mals that did not yet exhibit evidence of high IL4
exposure (19). Thus, IL-4 rather than acting via the CSF1R
appears to unleash macrophages from their dependence on
the CSF1R for proliferation.
IL-4 has the capacity to induce alternative activation as
well as proliferation in both resident and recruited settings
(13). This raised the fundamental question of whether
IL-4Ra-activated macrophages of distinct origin are
functionally similar. To address this P’ng Loke and col-
leagues (20) compared the transcriptome of resident versus
recruited macrophages exposed to IL-4 using delivery of IL-
4 into naive or thioglycollate-injected mice. The results dra-
matically illustrated that cellular origins impart a far larger
stamp on the transcriptome than IL-4 exposure. They further
demonstrated that many of the markers traditionally associ-
ated with alternative activation were only present on the
blood monocyte derived population, including the mannose
receptor, Raldh2 and PD-L2. The difference in Raldh2
expression translated into the ability of only monocyte
derived cells to promote the differentiation of FoxP3 cells
from naive CD4+ cells via retinoic acid production. In con-
trast, some IL-4-induced gene products, such as Uncoupling
protein 1, were seen only in the resident derived cells.
These phenotypic differences between cells of embryonic
origin versus bone marrow origin were verified in L. sigm-
odontis versus Schistosoma mansoni infections, respectively (20).
Thus, macrophage provenance is of critical importance in
understanding the outcome of a type 2 immune response.
In addition to the expansion of resident pleural macro-
phages in the L. sigmodontis model, we also observed that infec-
tion with the purely gastrointestinal nematode, H. polygyrus,
caused expansion of peritoneal resident cells. This was some-
what surprising, as the parasite does not enter the peritoneal
space. However, previous studies have shown the presence of
Th2 cells in the peritoneal cavity of infected mice (31), con-
sistent with our prediction that T-helper cells are instrumental
in inducing proliferation. In both the L. sigmodontis and
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H. polygyrus models, shielded bone marrow chimeras were
used to verify the resident origin of the pleural and peritoneal
macrophages, respectively. However, these infections may
prove to be exceptions to the rule and in many, if not most,
Th2 infections, there is likely to be recruitment of monocytes
from the blood. Because the importance of macrophage ori-
gins has only recently become recognized, little information
is available in different model systems, and thus we are rela-
tively ignorant of what determines when a recruited popula-
tion is dominant over resident expansion. Even in the
L. sigmodontis model, over time there is increasing numbers of
recruited monocytes (unpublished observation). We presume
that ‘non-inflammatory’ entry of the infective larvae com-
bined with local induction of IL-4 by innate cells means
blood cell recruitment is initially avoided. It may be that only
subsequent parasite death is sufficient to trigger monocyte
recruitment. In settings in which bacteria are present, such as
infection of the gastro-intestinal tract, monocyte recruitment
will likely dominate (28) (Fig. 2).
Two important papers have recently addressed macro-
phage origins in the liver of S. mansoni infected mice (32,
33). During patent S. mansoni infection, eggs become trapped
in the liver and these induce a host-protective Th2-mediated
granuloma, in which ΑΑΜΦ are a major component. Using
intra-vital imaging and cell transfer experiments with
Cx3Cr1GPF/+ mice, Girgis et al. (33) demonstrated that
ΑΑΜΦ in the liver granulomas arise predominantly from
blood monocytes. Similarly, Nascimento et al. (32) using
careful phenotyping of the developing granuloma and pulse
chase experiments demonstrate that the majority of macro-
phages are bone marrow derived. Importantly, Nascimento
et al. (32) show that there is robust infection-induced prolif-
eration of the resident macrophages, but this does not trans-
late into significant cellular expansion. The dominance of
the recruited monocyte population may reflect an inflamma-
tory environment caused by leakage of intestinal bacteria
into the portal bloodstream that may occur as eggs success-
fully cross into the gut lumen (32). Indeed, the authors
show that the macrophage phenotype is highly heteroge-
neous, with clear evidence of alternative activation but also
the production of iNOS and TNF. We have observed macro-
phage proliferation in the serous cavities, lamina propria, and
the lung in different Th2-inducing models (Fig. 1). Nasci-
mento et al. (32) extend these observations to the liver, but
illustrate that the dynamics by which macrophages accumu-
late are highly complex. Importantly, even when prolifera-
tion is not observed, this may be due to the narrow time
window in which proliferation can be seen (19). Thus, even
when it is straightforward to assess the tissue-resident versus
BM origin of macrophages in inflamed tissue, determining
whether the final numbers are the result of proliferation,
recruitment, or enhanced survival will still be challenging.
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With the new understanding of macrophage origins and
proliferation capacity, the functional potential of macro-
phages activated in type 2 immunity gains even more com-
plexity. However, at a more fundamental level we are still
remarkably ignorant of the specific contribution of IL-4Ra
activated macrophages to disease outcome in most type 2
disease settings. In the following sections, we discuss what
is currently known about the specific functions of AAMΦ
but also new leads from transcriptional analysis comparing
WT versus IL-4Ra/ macrophages (9).
Helminth killing
Immune-mediated killing of parasitic worms has been
repeatedly demonstrated in animal models, and, with rare
exceptions, type 2 immunity is required. In the case of sev-
eral gastrointestinal models, delivery of IL-4 and/or IL-13
alone triggers mucus production, smooth muscle contraction
and epithelial turnover, which is sufficient to mediate expul-
sion from the gut (34). More broadly IL-4 or IL-4 receptor
deficiency confers susceptibility on resistant murine strains
for a range of helminth infections (6). Helminth infected
humans are reported to display a ‘modified Th2’ response
that results from sophisticated adaptations employed by the
parasites to divert the host immune reaction as well as host
adaptations to avoid immune-mediated damage (35–37).
Together these allow chronic infections to establish and can
make deciphering the appropriate protective response diffi-
cult. This is further complicated by the dynamics of hel-
minth life cycles and life histories such that the killing
mechanisms depend on multiple factors that include the
developmental stage of the parasite as well as the tissue
through which the parasite migrates and eventually resides.
This complexity is exemplified by the model filarial nem-
atode, L. sigmodontis. In primary infection, over half of the
infective-stage L3 larvae are killed in the skin immediately
after infection or during their migration to the pleural cavity
(38). Once the remaining larvae make it to the pleural cav-
ity and start to undergo the molting process into L4 stage
larvae and adult worms, further killing is relatively slow.
Furthermore, the mechanisms by which the larvae and
adults are killed by the immune system differ (39). In sus-
ceptible but immunocompetent mouse strains (e.g. BALB/c)
this process can take several months (>90 days) and even in
resistant strains (e.g. C57BL/6) the parasites survive for sev-
eral weeks (approximately 40–50 days) (38). Similarly, on
secondary infection with the gastrointestinal parasite H. po-
lygyrus larvae are killed, but adult parasites implanted directly
into the gut lumen of the immune recipient can establish
patent infection (40). In general, early developmental stages
are more vulnerable to immune attack than later stages, per-
haps because of the superior ability of parasites that survive
to adulthood to modulate the host response (41). Some par-
asites create their own ‘immunoprivileged’ sites by forming
cysts (e.g. Echinococcus granulosus) which show a high degree of
immunomodulatory activity diverting potentially protective
immune responses (42). Thus, one aim of the immune
response is to trap parasites during their migration/develop-
ment before a successful immune evasion strategy is in
place. This appears to be the basis of most successful model
vaccines (43). For example, L. sigmodontis larvae exhibit lim-
ited migratory capacity in vaccinated mice (44), and H. po-
lygyrus larvae become trapped inside the gut wall in resistant
or immune mice (45, 46). A range of type 2 cytokines, cell
types, and antibodies have been implicated in protective
immunity in many different helminth models, but only
recently have macrophages been receiving due attention
(47).
The specific contribution of macrophages and, moreover,
IL-4Ra-dependent activation in the killing and expulsion of
helminths is still unclear. Macrophages make up a large pro-
portion of the cells present at the site of various helminth
infections (48) and are a major constituent of granulomas
forming around parasites (49–51). Macrophage depletion
using clodronate liposomes has demonstrated their impor-
tance for expulsion of intestinal parasites like Nippostrongylus
brasiliensis or H. polygyrus (28, 52). Similarly interference with
macrophage function through injection of carrageenan or
carbon particles enhances the survival of Brugia malayi and
B. pahangi larvae in the peritoneal cavity of infected animals
(53, 54). Of particular interest is recent data suggesting that
while macrophages are important in larval killing, they
don’t act alone. Bonne-Annee et al. (55, 56) demonstrated
that in vitro macrophages and neutrophils work together to
kill Strongyloides stercoralis larvae.
The evidence that macrophages are involved in worm kill-
ing is strong, but whether this requires alternative activation
or is possibly hampered by it is still contentious. In a very
recent study, expression of alternative activation markers
positively correlated with resistance to infection with H. po-
lygyrus and depletion of macrophages using clodronate lipo-
somes resulted in reduced resistance (51). However, the
study did not directly assess the role of the IL-4Ra, and it is
possible that although macrophages themselves might be
important for efficient killing of invading parasites the
© 2014 The Authors. Immunological Reviews published by John Wiley & Sons Ltd.
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IL-4Ra-mediated activation might not. Most of the studies
attempting to resolve the specific role of AAMΦ have used
mice with LysM-Cre mediated deletion of the floxed IL-4Ra
gene, which is relatively inefficient particularly on periph-
eral blood monocytes (57). Additionally, even if IL-4Ra-
induced macrophage genes contribute to worm killing,
these may be countered by proteins that inhibit Th2-
induced effector pathways. For example, Arginase and
RELMa, products strongly associated with alternative macro-
phage activation, can act as negative feedback regulators
directly limiting the Th2 response (58, 59). Thus, it may
not be surprising that efficient elimination of the gastroin-
testinal nematodes N. brasiliensis or Trichinella spiralis was unim-
paired in LysMCre IL-4Raflox/ mice relative to WT
(60–62). Critically, a role (or lack thereof) for AAMΦ in
one infection system may not apply to all nematode infec-
tions as the Th2 effector mechanisms involved can be quite
distinct (34, 63).
Data from our laboratory using the filarial L. sigmodontis
model suggest that there is a role for IL-4Ra-mediated mac-
rophage activation in the control of this tissue nematode
infection but also revealed a key difficulty with the LysMCre
mice in the context of IL-4Ra expression. Infected LysMCre
IL-4Raflox/ mice showed increased number of circulating
microfilaria at late stages of infection (Fig. 3) indicating a
role for AAMΦ in either killing the circulating microfilaria
or impairing female fertility. To our surprise, standard
markers of alternative activation (i.e. RELMa and YM1) in
the macrophage specific KO while absent as expected at day
10 were no different to wildtype animals at the late stage of
infection (d60). Because LysMCre-mediated deletion of the
floxed IL-4Ra gene is relatively inefficient (57) we predicted
that chronic IL-4 exposure was causing an outgrowth of IL-
4Ra sufficient macrophages, such that by day 60 post infec-
tion all macrophages were wildtype. This was consistent
with our data utilizing 50:50 WT:IL-4Ra/ chimeras
injected with IL-4, in which the WT macrophages outcom-
pete their gene deficient counterparts (19). The competitive
advantage during nematode infection was confirmed with
H. polygyrus, in which the proportion of RELMa positive peri-
toneal macrophages in LysMCre IL-4Raflox/ mice increased
from 4% in naive mice to 25% at day 14 and 70% by day
28, by which point >50% of the macrophages expressed the
IL-4Ra (19).
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Fig. 3. Expression of IL-4Ra by myeloid cells is required for optimal immune responses to filarial infection. BALB/c (blue squares; WT),
IL-4Ra-deficient (black circles; KO), IL-4Ra heterozygous (green upward triangles; het), or LysMCre IL-4Ra flox/ (red downward triangles; Cre)
were infected by subcutaneous injection of 25 L. sigmodontis L3 stage larvae. (A) At the indicated time points, 10 ll venous blood were collected
from each mouse and the number of microfilaria present assessed by microscopic analysis. Data points indicate mean and SEM of 4–5 mice per
group. (B) Number of adult parasites present in the pleural cavity of the mice analyzed in (A), 60 days after infection. Data points indicate
individual animals and lines indicate mean. (C) Percent Relm-a expressing macrophages 10 days postinfection in naive (N) or infected (I) BALB/
c (WT) or LysMCre IL-4Ra flox/ (Cre) mice. (D) Percent Relm-a expressing macrophages in the mice analyzed in A, 60 days postinfection.
Detailed description of materials and methods used in similar experiments can be found in van der Werf et al. (36) (A, B) and in Jenkins et al.
(13) (C, D).
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Because actual IL-4Ra deletion occurred only early in
infection, the data suggest AAMΦ act at early stages of infec-
tion to influence later resistance. That early events can deter-
mine the later outcome of infection is consistent with data
in which T-regulatory cell depletion just prior to L. sigmodon-
tis infection dramatically decreases microfilaria numbers at
day 60 (64). This hypothesis would also be in line with
data showing that host immune status at the time of infec-
tion influences parasite developmental rate and subsequent
fecundity (65). The failure of macrophages to efficiently
alternatively activate early in infection could therefore lead
to an altered parasite developmental program which allows
the parasite to produce more offspring. One caveat is that
LysMCre will also mediate IL-4Ra deletion in granulocytes,
and thus we cannot be certain that the impaired microfilarial
killing is specifically due to macrophages.
A recent report by Esser-von Bieren et al. (46) sheds new
light on the potential contribution of macrophages to nema-
tode killing. Using mice that lack antibodies (JH/) or
activating Fc receptors (FcRc/), they demonstrate in a
model of secondary H. polygyrus infection that antibodies acti-
vate macrophages to trap and immobilize infective larvae.
Arginase was important for killing as discussed below. In
this setting, the ability of antibodies to induce arginase was
independent of the IL-4Ra, but in its absence macrophages
fail to accumulate at the infection site (46). Thus, even if
the IL-4Ra is not always needed to induce macrophage
effector molecules, it may be essential to expand macro-
phages in sufficient numbers to perform non-IL-4Ra-depen-
dent functions.
It is therefore still early in our understanding of the
mechanisms by which AAMΦ may contribute to parasite
control. In the sections below, we discuss some of the
findings about well-known markers of alternative activation
and their role in resistance to helminth infection as well as
more recent data from our laboratory identifying potential
new effector molecules not previously associated with
AAMΦ. Due to the fact that parasites can survive for very
long periods of time in their respective hosts, it is
reasonable to expect that a range and combination of
different effector mechanisms need to work in concert to
achieve effective parasite expulsion or killing. Of note, sev-
eral AAMΦ products have been associated with an immune
modulatory function rather than direct anti-parasitic
effector responses. Thus, in many circumstances AAMΦ
may not have a primary role in parasite killing but act to
contain excessive inflammation and maintain tissue
homeostasis.
Effector molecules and pathways
Chitinase-like proteins
YM1 [chitinase-3-like-3 (Chi3l3)] is one of the most
highly expressed genes in alternatively activated macro-
phages (8, 9, 66). Upon activation with IL-4, macrophages
accumulate large amounts of intracellular YM1 that can be
readily detected by flow cytometry even without the use
of Brefeldin A or Monensin and is simultaneously released
in high quantities into the surrounding tissue (13, 67).
YM1 is part of the glycoside hydrolase family 18, which
includes enzymatically active, chitin-degrading enzymes
(i.e. chitotriosidase and AMCase) as well as enzymatically
inactive, chitinase-like proteins (CLPs), e.g. YM1, BRP39,
YM2 (reviewed in 68). Whereas the chitin-degrading
enzymes are highly conserved across the animal kingdom,
the CLPs represent relatively recent gene duplication events
in mammals and are highly diverse between species (69).
Because of the absence of direct homology between mouse
YM1 and human CLPs, the importance of studying murine
CLPs is sometimes questioned. However, CLP family mem-
bers are present in almost all mammalian species and are
undergoing apparently rapid evolution. This high diversity
and upregulation by IL-4 strongly suggests CLPs are
involved in protection against infection, and the fundamen-
tal mechanism of action is likely to be shared across spe-
cies.
AMCase and chitotriosidase, which actively degrade chi-
tin, are thought to be important in the defense against
fungal infections as well as in the degradation of inhaled
chitin (68, 70–72). Nance et al. (73) have elegantly dem-
onstrated that AMCase activity is essential to control chitin-
containing cysts in the brains of mice chronically infected
with Toxoplasma gondii. AMCase in humans and mice is
strongly associated with Th2 responses (68, 70), and
blockade of AMCase activity has profound consequences
for Th2 mediated, allergic airway inflammation (74). It is
therefore very likely that these molecules are involved in
protection against Th2-inducing chitin-containing nema-
todes. They may also contribute to degradation of chitin-
containing parasite-debris that is shed during molting.
Additionally, because chitin itself has profound effects on
the immune system (75), the ability to break down chitin
or even just bind to it, means these proteins will be
involved in shaping the immune response triggered by chi-
tin-containing parasites.
In contrast to the active chitinases, the function of YM1
and the other CLPs is still something of a mystery. This is
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despite a remarkable depth of knowledge on the structural
biology of these proteins, due to the propensity for YM1 to
form crystals (76–78). Although crystal formation has so far
only been described in the context of lung pathology, it is
feasible to speculate that the large quantities of YM1 pro-
duced in the direct environment of parasites are taken up
during feeding. Crystal formation could lead to internal dam-
age in the gastrointestinal system of the parasite. This is unli-
kely to be sufficient for parasite killing, as both C57BL/6 and
BALB/c mice produce relatively large quantities of YM1 in
response to L. sigmodontis infection but only C57BL/6 mice are
able to kill the parasites before patency (19, 79). Unlike
many other CLPs, YM1 does not actually bind chitin but has
been shown to bind components of the extracellular matrix
such as heparan sulfate (80). This would be consistent with a
tissue remodeling or repair function rather than active para-
site killing. YM1 has also been implicated in the immune reg-
ulation of T-cell responses by IL-4 activated dendritic cells in
vitro and in vivo (81–83) and has direct effects on CD8+ T-cell
proliferation (84). Taken together, YM1 is likely to have a
role in the defense against parasitic infections but this may be
through regulatory and tissue remodeling functions rather
than direct anti-parasite action.
RELMa/b
Another key molecule strongly associated with alternative
macrophage activation and thus potentially important for
the resistance against parasite infections is RELMa (Retnla)
(also called FIZZ-1). Indeed, more than arginase or YM1,
which can be induced by classical stimuli such as LPS (85,
86), upregulation of RELMa is typically very reliant on the
IL-4Ra for enhanced expression (13). It is important to
note, however, that macrophages are not the only RELMa
source. Eosinophils, neutrophils, and dendritic cells as well
as non-hematopoietic cells (e.g. epithelium) express RELMa
under certain circumstances (87–90). One argument for a
function in host defense is that RELMb, a closely related
family member produced by epithelial cells (91), plays a
direct role in the attrition and expulsion of intestinal, lumen
dwelling parasites (92). This effect seems to mainly be med-
iated by binding of RELMb to chemosensory organs of para-
sites (93) limiting worm chemotaxis and the location of
their food source eventually leading to starvation and death
(92). In contrast no direct interaction of RELMa with para-
sites or parasite products has been described so far and
somewhat surprisingly RELMa has instead been associated
with suppression of Th2 immune responses and reduced
resistance to gastrointestinal parasite infection (59, 87).
Furthermore RELMa from ‘alternatively activated’ dendritic
cells during the priming of a Th2 response in vitro leads to
enhanced IL-10 production from T cells (82) and RELMa
has been implicated in the induction of Th17-responses dur-
ing bacterial infection (94). Thus, one of the main effects of
RELMa seems to be the modulation of the adaptive immune
response limiting Th2 responses and enhancing Th17- or
regulatory responses. Nonetheless, RELMa may still promote
parasite resistance. For example, RELMa can act as a chemo-
attractant for eosinophils (95, 96), which are strongly con-
nected with resistance to certain parasite infections (97).
A critical function for RELMa may prove to be in the
regulation of host energy metabolism and glucose homeo-
stasis during infection. RELMa is related to resistin, a hor-
mone associated with insulin resistance (98) and has been
linked to glucose tolerance and the regulation of serum
leptin levels during colonic inflammation (90). RELMa
itself has a cholesterol-lowering effect and protects against
atherosclerosis in murine models (99). Although the
impact of this metabolic control on helminth infection
has yet to be determined, it is increasingly recognized
that alternative macrophage activation not only induces a
very distinct metabolic phenotype within the macrophage
but also affects the metabolism of the whole organism
(100–102). Thus, RELMa seems to adopt very diverse
roles dependent on the context and the infection site,
making its role in resistance to parasite infection difficult
to dissect. Moreover, whether these differences in func-
tionality are associated with different cellular sources or
specific modifications of the RELMa protein (e.g. proteo-
lytic cleavage, glycosylation etc.) remain to be elucidated.
Overall, unlike its sibling, RELMb, RELMa may have no
direct anti-parasite effects but instead may modulate the
host immune responses that affect worm survival and pro-
mote host tolerance to infection.
Arginase
The last of the ‘Big Three’ molecules associated with alterna-
tive activation of macrophages is arginase 1 (103). Arginase
1 is the enzyme that most typifies the immunomodulatory
and cross-regulatory nature of macrophage activation. Argi-
nase 1 competes with inducible nitric oxide synthase
(iNOS/NOS2) for their mutual substrate L-arginine. Because
iNOS is important in the production of reactive nitrogen
species and microbial killing, preferential expression of argi-
nase-1 in alternatively activated macrophages serves the dual
© 2014 The Authors. Immunological Reviews published by John Wiley & Sons Ltd.
Immunological Reviews 262/2014 121
R€uckerl & Allen  Macrophages in helminth infection
purpose of creating important anti-nematode mediators (see
below) as well as inhibiting concomitant NOS2 activity.
Importantly this inhibitory effect is not restricted to just
NO-production but also limits the release of pro-inflamma-
tory cytokines by macrophages and restricts inflammatory
cell recruitment during endotoxemia (104). Because argi-
nase activity can cause systemic changes in arginine avail-
ability, the immunosuppressive effects extend beyond
macrophage intrinsic effector functions and lead to impaired
T cell responses (104–107). Thus like YM1 and RELMa,
arginase 1 functions as a modulator of immune responsive-
ness. However, unlike YM1 and RELMa, arginase-1 has been
directly linked to resistance to helminth infections.
Depletion of macrophages or inhibition of arginase dur-
ing secondary infection with H. polygyrus results in loss of a
protective memory response and failure to expel the para-
sites (28, 51). Thus, although arginase expression can limit
immune responses including T cell activation, it also nega-
tively impacts on the invading parasite. Whether this is due
to a reduction in the availability of L-arginine to the grow-
ing parasite remains to be tested. More recent work suggests
an alternate mechanism of arginase 1-mediated parasite con-
trol. L-ornithine and polyamines, products of arginase 1
mediated arginine catabolism, reduced the migratory capac-
ity of H. polygyrus larvae in vitro (46) and inhibition of argi-
nase 1 prevented retention and trapping of N. brasiliensis
larvae in the skin of infected animals (108). Proline and
hydroxyproline, further downstream products of arginase
activity, are central constituents of collagen (109), a major
component of extracellular matrix, and are found at high
levels in S. mansoni-induced liver granulomas and therefore
potentially important in restricting larval migration. Thus,
the effects of arginase on parasite survival and resistance to
infection may in part be mediated through its well-known
role in tissue remodeling rather than immune modulation
or arginine removal. Of note, the Wynn laboratory (58)
found the consequences of arginase 1 expression depend on
the cellular source. In their model of liver fibrosis caused by
S. mansoni egg deposition, macrophage-derived arginase
expression was central to immunosuppressive and regulatory
but not pro-fibrotic functions. They propose that fibroblast
derived arginase is more important for extracellular matrix
deposition (58). Taken together, these studies illustrate that
both arginase expression and macrophages can be of central
importance in the resistance to helminth infections, but the
specific contribution of macrophage-derived arginase will
need to be assessed in each model.
INOS/ROS
As mentioned above, helminth infections are most com-
monly associated with a protective Th2 immune response
and alternative activation of macrophages. However, anti-
bacterial effector molecules such as reactive nitrogen or oxy-
gen species due to enhanced activity of the corresponding
enzymes (i.e. INOS, NOX) have been shown to effectively
kill helminth parasites in vitro (110, 111). Because this pro-
tection would come at the cost of enhanced pathology and
tissue destruction (7), such responses are usually tightly
controlled and suppressed. Nonetheless, several findings
indicate that components of type 1 immunity do contribute
to parasite killing and expulsion of helminth infections. For
example, a lack of IFNc and consequently reduced neutro-
phil accumulation has been associated with prolonged sur-
vival/persistence of adult L. sigmodontis worms in the pleural
cavity of infected mice (112). Similarly formation of extra-
cellular traps (NET), normally associated with the trapping
of bacteria and fungi, have been shown to effectively kill
S. stercoralis larvae in a collaborative effort of alternatively
activated macrophages and neutrophils (55). In the case of
the tapeworm Taenia crassiceps, type 1 responses and iNOS are
essential for resistance at the early stages of infection (113).
Thus, although pro-inflammatory responses are typically
suppressed during helminth infections, localized expression
(possibly in the context of granulomas as discussed below)
with tightly managed release of cytotoxic mediators might
provide additional means by which the immune system can
control helminth infections. It may also be that when the
type 2 effectors alone cannot effectively control infection,
the contribution of more inflammatory type 1 pathways are
a necessary risk, especially in the context of more lethal
infections, such as those caused by some tapeworm species.
Multinucleated giant cell formation
One characteristic of many helminth infections is the forma-
tion of dense granulomas around the invading parasite (50,
114). These usually consist of highly organized layers of
immune cells with macrophages forming a central part.
Some of these macrophages then fuse together to form mul-
tinucleate giant cells (MNGCs). MNGCs and granulomas
were originally described in the context of Th1-biased Myco-
bacterium tuberculosis infection and were thought to help pre-
vent the spread of infectious mycobacteria (115). It is
becoming more apparent, however, that granulomatous
reactions are also a central part of many Th2-mediated
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responses, and indeed seem to be an integral part of the
alternative activation program of macrophages. Many of the
molecules thought to be involved in the formation of
MNGC (e.g. E-cadherin, CD36, Mannose receptor) are also
markers of AAMΦ, and incubation of bone marrow derived
macrophages with IL-4 or IL-13 in vitro will lead to fusion
and MNGC-formation (116–119). The consequences of
macrophage fusion and granuloma formation during hel-
minth infections are not yet clear, but the encapsulation of
parasites may prevent them from causing excessive tissue
damage or, as discussed above, help to trap them in tissues
more easily accessible to immune cells (120). In this con-
text, Rajan et al. (49) showed that macrophages attached to
B. malayi larvae lead to deformations/changes in the underly-
ing cuticle of the parasite which allowed eosinophils to
transmigrate underneath the cuticle and potentially damage
the parasite. Partial encapsulation of parasites or simple
attachment of immune cells alone, however, does not seem
to be sufficient to efficiently kill adult parasites as we often
observe healthy looking motile filarial nematodes in which a
section of the parasite is encased in a granulomatous struc-
ture. Thus entrapment might just be the first step allowing
the immune system enough time to deploy additional
defense mechanisms.
Attachment of macrophages to introduced foreign mate-
rial (e.g. implants) creates a privileged space between the
cell-membrane and the surface of the material into which
degradative enzymes, acid, and reactive oxygen or nitrogen
intermediates can safely be released without risk of deactiva-
tion or damage to the surrounding tissue (116, 121). Mac-
rophage fusion increases the surface area covered by the
privileged space (122). MNGC-formation during nematode
infection might thus constitute a form of foreign body reac-
tion where the inability of individual macrophages to engulf
a particular parasite leads to their fusion in a process called
‘frustrated phagocytosis’ (121). These fused macrophages
help create a ‘restricted’ environment surrounding the para-
site in which secretion of actively ‘killing’ molecules or
removal of essential nutrients to starve the parasite, could
limit worm survival. A major chicken and egg question
remains: do parasites get encapsulated because they are
dying/damaged or does the encapsulation cause their death?
Complement
To develop both a broader and more detailed picture of the
function of the IL-4Ra on macrophages during nematode
infection, we recently performed an in-depth RNAseq analy-
sis of IL-4Ra-deficient and -sufficient macrophages elicited
by implantation of the peritoneal cavity with the nematode
B. malayi or exposure to thioglycollate (9). Surprisingly, one
of the most differentially regulated pathways in AAMΦ as
compared to thioglycollate elicited macrophages was the
complement and coagulation cascade (9). Although the
upregulation of the associated transcripts was not entirely
IL-4Ra dependent the sheer number of transcripts associated
with this pathway exceeded all expectations. C3, the central
component of all complement activation pathways, was
among the most abundant gene transcripts found in nema-
tode elicited AAMΦ. Under normal circumstances hepato-
cytes are the major source of C3 in serum. However, many
more cell types including macrophages and monocytes can
express complement factors locally (123). The functional
relevance of local versus systemic complement production,
however, is not well understood.
In the context of filarial nematode infection, the absence
of cellular recruitment might prevent the leakage of fluids
and serum components from the vasculature that would
normally occur during inflammatory processes (13). Thus,
local sources of these components may be required to allow
efficient accumulation of complement components at the
infection site, perhaps binding to the parasite and facilitating
the adherence of immune cells. The contribution of comple-
ment to nematode control has been demonstrated in recent
studies (46, 56), and the importance of local C3-production
is highlighted by the fact that parasitic nematodes have
evolved counter-measures to inactivate C3 (124). Of note
the induction of these counter-mechanisms seems to be
stage specific with early stage larvae being more susceptible
than adult parasites (125). Thus, local production of com-
plement factors by macrophages might allow rapid attack of
invading parasites and avoid the induction of inflammatory
processes that might lead to tissue damage. This hypothesis
is also supported by an earlier finding that activated C3 acts
as a chemokine attracting eosinophils but not neutrophils
and thus circumventing normal inflammatory recruitment
pathways (126).
It may also be that complement components are contrib-
uting to the anti-inflammatory environment of helminth
infection. C1q and C3, which are both highly upregulated
in AAMΦ (9), have been found to exhibit profound anti-
inflammatory properties. Pretreatment with C3 containing
serum enhances phagocytosis and uptake of Francisella tularensis
by human macrophages but simultaneously reduces NF-jB
signaling and pro-inflammatory cytokine secretion (127).
Similarly, uptake of C1q-bound apoptotic cells by human
macrophages alters LPS-induced cytokine production to a
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more immunoregulatory phenotype with increased release
of IL-10, IL-27, and IL-33 and reduced inflammasome acti-
vation (128). Thus, similar to the many AAMΦ effector
molecules, release of complement components during hel-
minth infection might serve a dual or even multiple pur-
poses; complement factors may allow efficient attachment of
cells to invading larvae and help to prevent patent infection,
while at the same time limiting excessive pro-inflammatory
responses and hence pathological sequelae. Dissecting the
contribution of complement to both host resistance to nem-
atode infection, and host tolerance through suppression of
inflammatory responses is an exciting area of future
research.
Metabolic re-programming and nutrient sequestration
Another very prominent characteristic evident from our
RNAseq data is the dramatic change in metabolic pathways
utilized by macrophages following parasite infection (9).
Changes in energy metabolism have been described for IL-4
activated macrophages before (100, 129) and indeed have
been described as a cardinal feature of alternative activation
(130). However, the extent to which these changes domi-
nate the alternative activation phenotype have not been fully
appreciated. Twenty-three of the 27 most highly regulated
pathways in nematode elicited macrophages were connected
to metabolic processes (9). Interestingly many of these path-
ways were also associated with amino acid degradation or
processing (alanine, aspartate and glutamate metabolism;
valine, leucine and isoleucine degradation; valine, leucine
and isoleucine biosynthesis; arginine and proline metabo-
lism; glycine serine and threonine metabolism). Given the
well documented role of nutritional immunity, i.e. the with-
holding of essential nutrients from invading pathogens, in
resistance to bacterial and intracellular infections (131,
132), it is feasible that these pathways perform a similar
role in helminth infection.
IL-4Ra has a major impact on the expression of specific
amino acid transporters in AAMΦ. In particular, there is
increased expression of transporters associated with arginine
uptake (Slc7a2, Slc7a4, and Slc36a2) and downregulation of
a transporter involved in arginine efflux (Slc7a8) (9). How-
ever, we do not know whether the differential regulation of
these pathways provides a means of removing essential
nutrients from the direct environment of the parasite and
eventually leading to its starvation, or whether they provide
building blocks for host metabolic processes. In this context,
it is important to note that transcripts associated with uptake
of metal ions (e.g. transferrin, S100a1) are also expressed at
enhanced levels by AAMΦ. Thus, AAMΦ seem to increase
the uptake of several essential nutrients. The metabolic
changes in nematode elicited macrophages provide an excit-
ing new avenue of investigation. Further research is required
to ascertain the functional consequence for the resistance to
helminth infection or indeed, tissue homeostasis during
infection, as discussed below.
Tissue repair
Macrophages are always present following tissue injury and
regulate all aspects of repair, from the initial inflammatory
phase, to cellular proliferation, angiogenesis, wound con-
traction, matrix deposition, and tissue remodeling and/or
scar formation (133, 134). Although the initial inflamma-
tory phase is typically associated with M1-type macrophag-
es, there is a large and growing literature documenting that
a reprogramming of macrophages away from an M1 pheno-
type promotes tissue repair and regeneration (reviewed in
135). These ‘repair’ macrophages are typically called M2,
but this encompasses an enormous range of potential phe-
notypes, and the specific contribution of IL-4Ra signaling to
repair and regeneration processes still needs to be eluci-
dated.
The evidence that IL-4Ra signaling on macrophages con-
tributes to repair is mainly circumstantial although increas-
ingly strong. The IL-4Ra dependent production of arginase
is one of the earliest and best examples. Arginase contributes
to tissue remodeling and repair because ornithine generated
by arginase activity can be converted to polyamines and
proline, supporting cell proliferation and collagen synthesis,
respectively (109). These properties also explain the fre-
quent association of arginase with fibrosis and in particular
asthma, where it is believed to contribute to pathological
tissue remodeling (136). Although it was the production of
arginase by ‘M2’ macrophages that was largely responsible
for them being associated with tissue repair, it seems that
the pro-fibrotic activity of arginase may not be macrophage-
derived. When arginase deficiency is restricted to macro-
phages, the T-cell suppressive but not the pro-repair/fibrosis
functions are mediated by macrophages (58). Nonetheless,
the ability to control inflammation is a critical component
of wound repair (137) and thus macrophage-derived argi-
nase is still likely to be an important player in many injury
contexts.
In addition to arginase, RELMa and the CLP YM1 are
highly but transiently upregulated in response to incisional
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wounding (21). Despite the reported failure to detect IL-4
or IL-13 in wounds (138), we found that the expression of
these markers was entirely IL-4Ra dependent during wound-
ing (21). There is considerable evidence for a pro-repair
role for RELMa. Several papers have documented the
angiogenic as well as mitogenic properties of RELMa in
vitro (139, 140). Indeed, instillation of recombinant RELMa
into the lungs of mice induced a similar phenotype as
seen after pneumonectomy with enhanced lung hyperplasia
and epithelial cell proliferation, typical signs of wound
healing (141). However, the contribution of RELMa to
repair may be highly complicated by its ability to suppress
Th2 responses (58, 59). So although RELMa has direct
repair functions, it also acts in a negative feedback loop to
control fibrosis. Thus, its role in injury and wound healing
is likely highly context dependent. CLPs, and in particular
YM1, are frequently identified at sites of injury. However,
until recently, direct evidence for involvement of CLPs in
repair, was lacking. In a bleomycin model of lung
injury, Zhou et al. (142) have now shown that Chi3l1
(BRP39) promotes repair through augmented alternative
macrophage activation, fibroblast formation, and matrix
deposition.
Many other repair proteins are regulated by IL-4 or IL-13
in macrophages contributing to the evidence that tissue pro-
tection is a key function for AAMΦ. For example, transcrip-
tionally, we observed that extracellular matrix degrading
matrix metalloproteases (MMPs) are actively downregulated
by IL-4Ra-mediated signaling in macrophages, while their
inhibitors (TIMP1 and TIMP2) are upregulated (9). Simi-
larly, we observe IL-4Ra dependent induction of insulin-like
growth factor 1 (IGF-1) during helminth infection (9) as
previously demonstrated in response to Th2 cytokines in vitro
(143). IGF-1 has a long established role in repair in part
through its ability to stimulate the proliferation and survival
of fibroblasts and myofibroblasts and to promote matrix
production and wound closure (144, 145). The importance
of IGF-1 in repair during helminth infection was illustrated
in a recent study by Chen et al. (146), in which IGF-1-pro-
ducing AAMΦ were needed to prevent excessive tissue
destruction and hemorrhage caused by lung migrating lar-
vae.
Although more direct evidence is needed, there is little
question that macrophages activated via the IL-4Ra
contribute to repair. Wound repair, especially in adults, is
often associated with scar tissue and when excessive leads
to fibrosis. It has been proposed that wound healing is
evolutionarily optimized for speed of healing under dirty
conditions and thus scar tissue may be the price mammals
must pay to close wounds sufficiently rapidly to avoid
infection (147). Because it seems likely that a fundamental
function of type 2 immunity is to accelerate repair, it is
not surprising that AAMΦ and their products are associated
with fibrosis (2). The future challenge will be to identify
the specific functions of AAMΦ-derived repair molecules in
specific settings and, if at all possible, to identify
pro-repair versus pro-fibrotic pathways. This will require
testing the quality and rate of repair in macrophage
specific deletions of the IL-4Ra as well as individual
effector molecules.
Because macrophages are rapidly recruited to the site of
tissue injury, the predominant source of ‘wound’ macro-
phages are likely to be blood-circulating monocytes. The
currently held view is that the early Ly6Chi monocytes are
replaced by Ly6Clo ‘patrolling’ monocytes as repair pro-
gresses. Indeed, the inflammatory monocytes may only be
needed to control potential infection, with the later stage
macrophages more essential for full repair (133). However,
with our growing understanding of the importance and lon-
gevity of tissue-resident macrophages, it seems likely that in
many contexts tissue-resident macrophages will contribute,
particularly at later stages of repair, when the inflammatory
monocytes have gone. If so, they will need to expand in
number, potentially by IL-4, or perhaps CSF-1 driven prolif-
eration.
Suppressing inflammation
IL-4 has long been considered an anti-inflammatory cyto-
kine (148), and macrophages activated by IL-4 have impor-
tant functions in suppressing immune responses (reviewed
in 48). Inflammation needs to be controlled to allow effec-
tive wound repair (137), and thus, the anti-inflammatory
nature of AAMΦ is intimately linked to their wound repair
phenotype. This makes evolutionary sense in the context of
the adaptive type 2 response: a host infected with macropar-
asites would want to repair any damage caused by a large
tissue migrating parasite but also avoid the serious collateral
consequences of mounting an inflammatory response to the
pathogen.
The data supporting an anti-inflammatory role for AAMΦ
have come from many laboratories and has been mostly
based on the evidence that AAMΦ are important sources of
immunosuppressive cytokines. These include TGF-b (149,
150), PGE2 (151), and the IL-1 receptor antagonist (149,
152). The chemokine expression profile is also strongly
associated with a non-inflammatory role (153) indicated by
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specific downregulation of key pro-inflammatory chemokin-
es via IL-4 (8, 9, 152).
The ability of a single protein to be both anti-inflamma-
tory and a central mediator of repair is demonstrated by
TGF-b, which is known for both immune suppression and
fibrosis (154). This functional duality is typical of many
Th2-activated macrophage products. As discussed earlier,
Arg-1 promotes collagen deposition on one hand but inhib-
its nitric oxide production and T-cell activation on the
other. 12/15 lipoxygenase, a protein strongly associated
with IL-4 activation of macrophages in both mice and peo-
ple, is needed for effective wound repair (155) but attenu-
ates pro-inflammatory macrophage activation (156). RELMa
exhibits angiogenic properties (139) and YM1/2 bind extra-
cellular matrix (157), but these are also implicated in regu-
lating inflammation (59, 81, 87). Similarly, Chi3l1
contributed to repair in a model of bleomycin-induced lung
injury both through direct repair functions and suppression
of inflammation (142). Thus, modulation of inflammation
is intrinsically linked to wound repair and an important
characteristic of AAMΦ.
Although IL-10 is very strongly associated with a M2 phe-
notype and is often listed as a prototypic cytokine associated
with alternative activation (47, 149), new sequencing tech-
nologies and tools for assessing cell-specific expression in
vivo, have made the story more complicated. Despite abun-
dant expression of the IL-10 receptor, YM1, RELMa, argi-
nase and many other AA markers, RNAseq analysis of
nematode-elicited macrophages had sufficient depth of
coverage to be able to say that IL-10 is not produced by
F4/80hi macrophages in this context (9). The important
source of IL-10 following both hookworm migration
through the lung and filarial nematode infection appears to
be T cells (146, 158). This is consistent with recent data
showing anti-inflammatory functions of gut macrophages
are mediated not by their ability to produce IL-10 but by
IL-10 receptor expression (159). The lack of IL-10 produc-
tion by AAMΦ may be surprising considering the known
ability of macrophages to produce IL-10 in response to
antibody cross-linking (160), and indeed we would
expect antibodies to be present in the helminth models dis-
cussed above. However, IL-10 production by macrophages
may require additional signals, such as TLR ligands and type
1 interferons (161, 162), that may not be present in these
nematode infection sites. The absence of macrophage
derived IL-10 despite high levels of parasite specific
antibody and antigen, may be further explained by Fcc
receptor usage on AAMΦ during helminth infection. We
found that IL-4Ra signaling drives a switch from the activat-
ing Fc receptors involved in IL-10 production (160) to the
inhibitory FccrIIb (9, 163).
The combined anti-inflammatory/wound healing function
of AAMΦ is strongly supported by a study of S. mansoni
infection in mice that lack the IL-4Ra specifically on macro-
phages and neutrophils but have otherwise intact Th2
responses (60). Following S. mansoni infection, these mice
died from overwhelming inflammatory responses in the
intestine and leakage of bacteria into the blood. Although
not conclusive evidence, the data strongly suggest that in
the absence of AAMΦ, these mice were unable to repair the
damage caused by egg migration through the intestinal wall
and the subsequent septic inflammation (60). The specific
roles Th2-induced proteins play in the complex orchestra of
tissue repair and remodeling are still to be established, but a
rapid shutdown of the inflammatory response to injury is
likely an important contribution.
Immune regulation
A paradox that still needs to be resolved is that AAMΦ,
which actively proliferate in vivo, are profoundly antiprolifer-
ative ex vivo. AAMΦ suppress proliferation of cells with
which they are co-cultured ex vivo in an IL-4-dependent
manner (150, 164). This property was our first insight into
the distinct function of macrophages under IL-4Ra control
and has been reproduced in many laboratories where sup-
pression has been attributed to arginase depletion (58),
TGF-b (165), PD-L pathway (166, 167), and 12/15 lipoxy-
genase (168). Of note, rapid division of immune cells (i.e.
effector T cells) has previously been shown to be highly
reliant on glucose and the Warburg effect (169). In con-
trast, alternative activation and also IL-4-driven proliferation
of macrophages are dependent on fatty acid oxidation and
oxidative phosphorylation (OXPHOS) (100) (Fig. 4). The
reasons for these metabolic differences are not yet com-
pletely clear. Studies in T cells suggest that aerobic glycolysis
allows for quick accumulation of biomass needed for cellu-
lar expansion whereas OXPHOS is associated with the
enhanced lifespan of memory T cells (170, 171). In an anal-
ogous manner, the utilization of OXPHOS in AAMΦ might
impart slightly slower proliferative expansion but allow the
expanded population to survive for a longer period of time.
Another hypothesis is that metabolic differences are linked
to the anatomical location in which cellular expansion is
likely to occur. T cells normally expand within lymphoid
structures which are surrounded by adipose tissue and well
vascularized (172, 173). Thus, it is feasible to assume that
© 2014 The Authors. Immunological Reviews published by John Wiley & Sons Ltd.
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these structures provide ample nutrients for optimal, rapid
cellular expansion. In contrast AAMΦ expand in the tissues
in response to IL-4 (13). In the presence of a large, tissue-
destructive macroparasite and the accompanying wound
healing process, these might suffer from acute shortage of
essential nutrients, especially glucose. Thus, the adoption of
OXPHOS as a means of generating energy might be neces-
sary to allow the expansion of tissue-resident macrophages
during helminth infection. In this context, it is interesting
to note that certain tumor cell lines, normally well known
for their high glucose consumption and glycolytic energy
metabolism, adopt OXPHOS to maintain cellular prolifera-
tion under low glucose conditions (174). Furthermore, we
observe a highly significant increase in expression of the
arginine transporter CAT2 (Slc7a2), as well as other amino
acid and nutrient transporters in response to IL-4Ra signal-
ing in AAMΦ (9). Transporter upregulation, in addition to
the above-discussed effector functions, might allow macro-
phages to acquire essential nutrients needed for expansion.
Thus, the anti-proliferative effect of AAMΦ on bystander
cells in vitro might at least in part be a side effect of nutrient
sequestration to which T cells are highly sensitive (175).
Critically, whether AAMΦ directly affect T-cell prolifera-
tion and polarization in vivo is not known. Although individ-
ual molecules expressed by AAMΦ (i.e. RELMa, YM1,
arginase) have been associated with immune suppression
(58, 59, 87), it is not always clear whether it is expression
by macrophages that imparts this effect. Indeed, our RNAseq
data indicate a remarkable lack of chemokine receptor
expression on nematode elicited macrophages (9), suggest-
ing that these cells are prone to stay in the tissues and most
likely do not migrate to the draining lymph nodes to direct
immune response. Thus, the immune regulation observed in
vivo (58, 59, 87) might rather be due to other cells, such as
DCs (82), expressing AAMΦ-associated molecules or due to
alternative activation of macrophages resident within the
lymphoid structures (79). Undoubtedly AAMΦ do influence
the local immune milieu in the tissues. Recruitment of eo-
sinophils to the site of helminth infection is greatly
enhanced by the presence of AAMΦ (176) and recruitment
of monocytes and neutrophils is discouraged by IL-4 (9,
19). Thus, AAMΦ contribute to regulating cells in their
immediate vicinity via various means and although it has
yet to be documented, local T-cell proliferation may also be
prevented. As described above in the context of comple-
ment, a major feature of AAMΦ may be to regulate the local
immune environment and mediate key necessary effector
functions, leaving more systemic immune regulation to
other cells. In this context, the local expansion of the
resident population and avoidance of pro-inflammatory
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Fig. 4. Inhibition of fatty acid oxidation blocks macrophage alternative activation and proliferation in vivo. C57BL/6 mice were injected i.p.
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recruitment makes sense; shaping a ‘safe’ environment for
the control of helminth infection or to mediate repair.
Plasticity
Classical macrophage activation, as found during bacterial
infections, and IL-4Ra-mediated alternative activation are
two extremes of a wide spectrum of overlapping activation
phenotypes (160). Although differentially activating stimuli
will block or reduce opposing activation signals, macro-
phages are known to be highly plastic and rarely exhibit
fixed phenotypes. Instead they form a continuum, adopting
characteristics of activation as needed according to their
environment (177). The lack of a fixed activation state is
supported by data showing that once the initial stimulating
agent is removed, macrophages quickly lose their activation
phenotype (178, own unpublished data) and cells isolated
from one activating environment subjected to an opposing
stimulus will adopt characteristics of the newly activating
environment (179). Indeed, macrophages isolated from
B. malayi infected animals and subjected to stimulation with
LPS/IFNc readily express pro-inflammatory cytokines (e.g.
IL-6, IL-10, TNF) and are able to control intracellular repli-
cation of Leishmania mexicana parasites (85). This flexibility in
activation phenotype, demonstrated in vitro, is presumed to
be important in the context of co-infections allowing mac-
rophages to quickly adapt to new challenges.
Changes in macrophage activation phenotype in vivo have
been demonstrated in the setting of wound healing, where
initially pro-inflammatory macrophages eventually convert
to a more anti-inflammatory phenotype (138). Conversely
we have reported a change in cytokine expression by mac-
rophages isolated from B. malayi infected mice early or late
following parasite implantation, with an increase in pro-
inflammatory cytokine production at later stages (180).
However, in vivo macrophage activation, especially in the
context of infection, is rarely homogenous, and only a sub-
set of macrophages will show signs of activation (13, 32,
181). Thus, adaptation to environmental changes could at
least in part be due to induction of differentially activated
subsets of macrophages, rather than true plasticity. More-
over, waves of cellular recruitment/expansion of various
macrophage populations might be favored over re-polariza-
tion of the existing already activated population. Thus,
despite clear evidence of macrophage plasticity in vitro, mac-
rophage plasticity during infection has to be re-evaluated.
This is especially true in light of our new understanding of
macrophage origins and proliferation (24) and the findings
by Gundra et al. (20). Macrophages derived from different
cellular sources (i.e. blood monocytes versus tissue-resident
macrophages) respond differently to the same stimulus (i.e.
IL-4) with potentially different functional activation out-
comes. Of note, functional differences between resident and
monocyte-derived macrophages have been described previ-
ously. Uderhardt et al. (182) showed preferential uptake of
apoptotic cells by resident peritoneal macrophages over
inflammatory monocyte-derived cells. Disruption of this bias
through genetic ablation of 12/15 lipoxygenase resulted in
presentation and recognition of self-antigens leading to
autoimmune reactions and lupus-like symptoms (182). Fur-
thermore, although B. malayi derived AAMΦ readily upregu-
lated iNOS and pro-inflammatory cytokine-production
following stimulation with LPS/IFNc, we were never able to
detect release of IL-12 from these cells, normally a key fea-
ture of classical macrophage activation (85). Thus, it is
likely that epigenetic or otherwise mediated determinants of
macrophage phenotype are induced during development
restricting the plasticity/variation in responses (178, 183).
Nonetheless, bone marrow-derived macrophages can
adopt a resident-like phenotype and re-populate the tissues
after lethal irradiation (24). Thus, these developmental
restrictions may be imposed by the local environment rather
than in the bone marrow or during embryogenesis. Local
regulation of macrophage identity was highlighted in two
recent studies, in which expression of the transcription fac-
tor GATA6 was shown to be essential for the resident peri-
toneal macrophage phenotype (184, 185). Furthermore, all-
trans retinoic acid and omentum-derived soluble factors
could drive expression of resident peritoneal macrophage
signature genes in bone marrow derived macrophages in vitro
(184). Thus, the environment of the peritoneal cavity seems
necessary and sufficient to induce the resident phenotype.
Although this does not occur in monocyte derived macro-
phages present in the peritoneal cavity under normal cir-
cumstances it highlights the context dependency and
flexibility of macrophage phenotypes. In this context, the
macrophages recruited to the site of B. malayi implant, as
analyzed in our RNAseq analysis, are monocytic in origin
(authors’ unpublished data). Despite clear evidence of pro-
liferation and adoption of a resident-like phenotype (i.e.
F4/80high, MHC-II low) (13), data from protected irradiated
chimeras suggest that an initial inflammatory influx, caused
by the wounding of the surgical incision, leads to the accu-
mulation of monocyte derived cells which are then con-
verted to a resident like phenotype. Thus, in addition to
© 2014 The Authors. Immunological Reviews published by John Wiley & Sons Ltd.
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driving proliferative expansion of resident and monocyte-
derived macrophages, IL-4 seems to enhance or enable
the conversion of monocyte derived macrophages to a resi-
dent phenotype. Consistent with this hypothesis, macro-
phages from B. malayi implanted animals showed highly
enhanced GATA6 expression as compared to thioglycollate
elicited macrophages (9), and IL-4 induces GATA-6 expres-
sion on thioglycollate-elicited macrophages (20). The func-
tional consequences of cellular source, proliferative
expansion, and long-term residence of tissue macrophages
on the resistance to helminth infection remain a wide open
question.
The future
We are entering a new era in macrophage biology, particu-
larly in light of our new understanding of cellular origins.
New questions are emerging daily, and we have raised many
of them here in this review. For example, in the context of
helminth infection, how do single molecules perform such
diverse functions as parasite killing, immune suppression, and
wound repair? More broadly, what is the extent of macro-
phage plasticity? Do recruited cells truly become fully func-
tional resident cells? What are the epigenetic/transcriptional
controls that regulate these functions both during develop-
ment and locally in the tissues? New tools (186, 187) and
collaborations with different disciplines from stem cell biol-
ogy to systems biology will allow us to unravel some of the
enormous complexity underlying macrophage function in
health and disease. Studying these intricate dynamics in the
context of infection with helminths, our ancient evolutionary
partners, will further enhance our fundamental understanding
of macrophage biology. The challenge will be to translate this
new knowledge into the ability to fine tune responses to the
benefit of infected or injured hosts.
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